Literature DB >> 11441549

Hepatocellular carcinoma recurrence after percutaneous ablation therapy: helical CT patterns.

O Catalano1, R Lobianco, M Esposito, A Siani.   

Abstract

BACKGROUND: To categorize the helical computed tomographic (CT) intrahepatic recurrence patterns of hepatocellular carcinoma (HCC) after treatment with percutaneous ablation procedures.
METHODS: Double-phase helical CT studies of 67 patients with HCC recurrence were reviewed. The study population had undergone percutaneous ablation therapy procedures (multisession or single-session ethanol injection therapy, radiofrequency thermal ablation therapy, and interstitial laser photocoagulation therapy) for 120 HCC nodules.
RESULTS: Four patterns were defined. (A) Enhancing tissue within the edge of the ablated nodule on arterial phase images (ingrowth): this pattern was seen in five treated lesions (4.2% of all treated nodules) in five patients (7.5% of all patients with recurrence) 3-7 months after treatment (mean = 4 months). (B) Enhancing tissue around the treated nodule but continuously to its border on arterial-phase images (outgrowth): this pattern was found in 12 (10%) treated lesions in 12 patients (18%) 3-6 months after ablation (mean = 4 months). (C) Enhancing tissue within the same segment of the treated nodule on arterial phase images (spread): this pattern was detected in 10 (8%) treated lesions in 10 patients (15%) 3-6 months after treatment (mean = 5 months). (D) Enhancing tissue within different segments from the treated nodule on arterial phase images (progression): this pattern was identified in 34 patients (51%) with 53 (44%) treated tumors 5-22 months after ablation (mean = 8 months). A mixed pattern was found in six subjects (9%) with seven (6%) treated nodules. Among the 61 patients with a nonmixed pattern, there were 85 treated nodules with persistent necrosis, 17 treated nodules with local recurrence (pattern A or B), and 107 new nodules due to nonlocal recurrence (pattern C or D). Portal phase enhanced images and especially unenhanced images showed a lower detection rate and a lower lesion-to-liver conspicuity score (for all patterns but mainly for pattern C).
CONCLUSION: Four patterns of recurrence after percutaneous ablation procedures can be categorized on double-phase helical CT and are best depicted on arterial phase images. Knowledge of these patterns is relevant for early detection and may be helpful in understanding the recurrence mechanism.

Entities:  

Mesh:

Year:  2001        PMID: 11441549     DOI: 10.1007/s002610000199

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN: 0942-8925


  9 in total

1.  3D versus 2D contrast-enhanced sonography in the evaluation of therapeutic response of hepatocellular carcinoma after locoregional therapies: preliminary findings.

Authors:  Tommaso Vincenzo Bartolotta; Adele Taibbi; Domenica Matranga; Massimo Midiri; Roberto Lagalla
Journal:  Radiol Med       Date:  2015-02-20       Impact factor: 3.469

2.  Power Doppler ultrasonography with time-signal intensity curves in monitoring hepatocellular carcinoma and liver metastases after intralesional therapy.

Authors:  R Farina; F Pennisi; G Mazzone; M Pennisi; G Riva; P V Foti; C Puglisi; G C Ettorre
Journal:  Radiol Med       Date:  2008-09-26       Impact factor: 3.469

3.  Intrahepatic distant recurrence after radiofrequency ablation for a single small hepatocellular carcinoma: risk factors and patterns.

Authors:  Yusuke Okuwaki; Takahide Nakazawa; Akitaka Shibuya; Koji Ono; Hisashi Hidaka; Masaaki Watanabe; Shigehiro Kokubu; Katsunori Saigenji
Journal:  J Gastroenterol       Date:  2008-02-24       Impact factor: 7.527

4.  Sonazoid-enhanced sonography for guiding radiofrequency ablation for hepatocellular carcinoma: better tumor visualization by Kupffer-phase imaging and vascular-phase imaging after reinjection.

Authors:  Noriyuki Miyamoto; Kazuhide Hiramatsu; Kazuhiko Tsuchiya; Yukihiko Sato; Satoshi Terae; Hiroki Shirato
Journal:  Jpn J Radiol       Date:  2009-06-06       Impact factor: 2.374

5.  Evaluation of cancer treatment in the abdomen: Trends and advances.

Authors:  Silanath Peungjesada; Hubert H Chuang; Srinivasa R Prasad; Haesun Choi; Evelyne M Loyer; Yulia Bronstein
Journal:  World J Radiol       Date:  2013-03-28

6.  Carbon dioxide microbubbles-enhanced sonographically guided radiofrequency ablation: treatment of patients with local progression of hepatocellular carcinoma.

Authors:  Noriyuki Miyamoto; Kazuhide Hiramatsu; Kazuhiko Tsuchiya; Yukihiko Sato
Journal:  Radiat Med       Date:  2008-02-27

7.  Feasibility of CT-CT fusion imaging for evaluation of the cryoablation margins in visible hepatocellular carcinoma on unenhanced CT images: Initial experience.

Authors:  Chao Chen; Yaohui Wang; Guodong Li; Lichao Xu; Ying Wang; Haozhe Huang; Biao Wang; Wentao Li; Xinhong He
Journal:  J Interv Med       Date:  2019-09-09

8.  Early Assessment of Response to Radiofrequency Ablation With CT Perfusion Imaging in Rabbit VX2 Liver Tumor Model.

Authors:  Xiaofei Yue; Xiangjun Dong; Mengting Huang; Hongli Yang; Kun Qian; Changhong Yi; Osamah Alwalid; Yanqiao Ren; Ping Han; Qian Li
Journal:  Front Oncol       Date:  2021-11-25       Impact factor: 6.244

9.  Dynamic Three-Dimensional Contrast-Enhanced Ultrasound to Predict Therapeutic Response of Radiofrequency Ablation in Hepatocellular Carcinoma: Preliminary Findings.

Authors:  Jiaying Cao; Yi Dong; Feng Mao; Wenping Wang
Journal:  Biomed Res Int       Date:  2018-08-26       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.